Study of PROXimology in seveRe persistent Asthma

{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}},{"value":"Aged (65 to 79 years)","concept":{"vocab":"MeSH","vocabURI":"D000368"}}],"level_type_clusion_I":"General population","level_type_clusion_other":"","clusion_I":"Patient inclusion Criteria : - Ambulatory patients, able to cooperate, of either sex, at least 18 years of age. ","clusion_E":"micronized forms in metered-dose inhalers,≥800 µg/d of beclometasone dipropionate in micronized form in metered-dose inhalers or ≥800 µg/j of budesonide or ≥500 µg/d of fluticasone propionate) and of inhaled long-acting ß2 agonists, administered:either in the form of two specialties using one or two of the following inhalers: Aerolizer®, standard metered-dose inhaler, Autohaler, Diskus®, Turbuhaler®,or in the form of a fixed association using one of the following inhalers: standard metered-dose inhaler, Diskus®, Turbuhaler®. - Patients with FEV measurement in the previous month. - Patients who brought their inhaled steroid treatment and inhaled long-acting ß2-agonist at the time of consultation. - Patients in couple whether or not married - Patients and relatives agree to participatePatientCriteria :- Patients with a non-asthmatic OCPD. - Patients who had inhaled steroids or lLABA treatment change in the previous three months (add-on or change of drug, posology change). - Patients and relatives refusing to participate to the study - Parents/ those close unable to complete a self-questionnaire. - Patients who do not live as a couple"}